Professor Bernard Yan
Professor Bernard Yan is both Neurologist and Endovascular Neurointerventionist in Royal Melbourne Hospital, Australia. His clinical expertise is in stroke intervention and aneurysms. Since employment in 2005 at the Department of Medicine, University of Melbourne, Bernard Yan has pursued an academic interest in cerebrovascular disease research. He has published 186 academic papers in peer-reviewed medical journals (SCI) achieving an h-index of 32 with > 7000 citations. He is the principal investigator of several international studies in cerebrovascular diseases including DIRECT-SAFE in which he is the co-principal together with Professor Peter Mitchell. He is the awardee of academic grants by the National Health and Medical Research Council (NHMRC). His other key research interests include the development of portable mobile wireless sensors for the intensive monitoring of patients with neurological diseases. He is actively involved in the development of novel microcatheters for the treatment of cerebrovascular diseases. He is also the co-inventor and holder of patent of the Neuroglide micronavigational system. His administrative responsibilities include Treasurer (2014 onwards) of the World Stroke Organization (WSO) and Vice-President of the Stroke Society of Australasia. He is the founding organizer of the Australia and China Training Initiative of Neurology (ACTION) programme. The programme is in its 9th year of operations and has successfully trained over 300 young neurologists from China.
A/Professor Andrew Lee
Professor Mark Parsons
Mark Parsons is an internationally recognised leader in Stroke Research and is a national leader in Stroke and Neurology clinical service and education. He holds the Royal Melbourne Hospital Professorial Chair of Neurology, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and is the new Director of the Department of Neurology, Royal Melbourne Hospital. He is an Honorary Professorial Fellow, The Florey Institute of Neuroscience and Mental Health. He is also an Honorary Professor at Fudan University, Shanghai.
Prof Parsons is the immediate past president of the Stroke Society of Australasia and has chaired the Australasian Stroke Trials Network. He has recently been elected to the Australian and New Zealand Association of Neurologists (ANZAN) Council. He has served on steering committees for >10 major stroke clinical trials, including leadership of the pioneering phase II and phase III clinical trials of tenecteplase. Previously he has been the Director, Priority Research Centre for Stroke and Traumatic Brain Injury, University of Newcastle, Member; Hunter Medical Research Institute Board (Area Health Service Representative), Professor of Medicine (Neurology), Faculty of Health and Medicine, University of Newcastle and Director, Acute Stroke Service, John Hunter Hospital, Newcastle.
Prof Parsons’ work using magnetic resonance and CT imaging techniques to study stroke pathophysiology and new therapeutic approaches, and translate them into clinical practice is internationally recognised. He is the Winner, NSW Health Awards, Translational Research Category: Transforming Acute Stroke Care Locally and Globally (2015); the Hunter Medical Research Institute Director’s Award for Mid-Career Research (2014); the University of Newcastle Alumni Medal Winner for outstanding achievement (2012). This is the major annual award for Alumni of the University of Newcastle. He was awarded the Faculty of Health Award for Researcher of the Year in 2011; and the ANZAN Leonard Cox Award in 2008. This is awarded for significant contributions to neuroscience research in the 10 years since becoming a neurologist.
Professor Stephen Davis